Log in to save to my catalogue

Drug‐induced cholestasis

Drug‐induced cholestasis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f6ff9dc98244b81a6b7522cd93895ed

Drug‐induced cholestasis

About this item

Full title

Drug‐induced cholestasis

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Journal title

Hepatology communications, 2017-10, Vol.1 (8), p.726-735

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

More information

Scope and Contents

Contents

Cholestatic drug‐induced liver injury (DILI) can be a diagnostic challenge due to a large differential diagnosis, variability in clinical presentation, and lack of serologic biomarkers associated with this condition. The clinical presentation of drug‐induced cholestasis includes bland cholestasis, cholestatic hepatitis, secondary sclerosing cholang...

Alternative Titles

Full title

Drug‐induced cholestasis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3f6ff9dc98244b81a6b7522cd93895ed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3f6ff9dc98244b81a6b7522cd93895ed

Other Identifiers

ISSN

2471-254X

E-ISSN

2471-254X

DOI

10.1002/hep4.1088

How to access this item